参考文献/References:
[1] Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease severity by position emission tomography. Comparison with quantitative arteriography in 193 patients[J]. Circulation, 1989, 79(4):825-835. DOI:org/10.1161/01.CIR.79.4. 825.
[2] Tamaki N, Ruddy TD, Dekamp R, et al. Myocardial perfusion[M]//Wahl RL, Buchanan JW. Principles and Practice of Positron Emission Tomography. Philadelphia:Lippincott, Williams & Wilkins, 2002:320-333.
[3] Sampson UK, Dorbala S, Limaye A, et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease[J]. J Am Coll Cardiol, 2007, 49(10):1052-1058. DOI:10.1016/j.jacc.2006.12.015.
[4] J Epstein N, Benelfassi A, SB Beanlands R, et al. An 82Rb infusion system for quantitative perfusion imaging with 3D PET[J]. Appl RadiatIsot, 2004, 60(6):921-927. DOI:10.1016/j.apradiso.2004. 02.002.
[5] Anagnostopoulos C, Almonacid A, El Fakhri G, et al. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity[J]. Eur J Nucl Med Mol Imaging, 2008, 35(9):1593-1601. DOI:10.1007/s00259-008-0793-2.
[6] Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis[J]. N Engl J Med, 1994, 330(25):1782-1788. DOI:10.1056/NEJM199406233302503.
[7] Di Carli M, Czernin J, Hoh CK, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease[J]. Circulation, 1995, 91(7):1944-1951. DOI:org/10.1161/01.CIR.91.7.1944.
[8] Lubberink M, Harms HJ, Halbmeijer R, el al. Low-Dose Quantitative Myocardial Blood Flow Imaging Using 15O-Water and PET Without Attenuation Correction[J]. J NuclMed, 2010, 51(4):575-580. DOI:10.2967/jnumed.109.070748.
[9] 李帅, 李剑明. 18F标记新型正电子心肌灌注显像剂的研究进展[J]. 中国医学影像技术, 2014, 30(6):926-929.Li S, Li JM. Progresses of new myocardial perfusion imaging agents labeled with 18F[J]. Chin J Med Imaging Technol, 2014, 30(6):926-929.
[10] Berman DS, Germano G, Slomka PJ. Improvement in PET myocardial perfusion image quality and quantification with flurpiridaz 18F[J]. J Nucl Cardiol, 2012, 19 Suppl 1:S38-45. DOI:10.1007/s12350-011-9487-4.
[11] 彭程, 赵祚全, 陈淑婷, 等. 18F标记的新型鏻正阳离子PET心肌灌注显像剂的制备及生物性能评价[J]. 同位素, 2014, 27(4):223-229. DOI:10.7538/tws.2014.27.04.0223. Peng C, Zhao ZQ, Chen ST, et al. Preparation and biological evaluation of novel 18F-labeled phosphonuimcation for myocardial perfusion imaging with PET[J]. J Isotopes, 2014, 27(4):223-229.
[12] 王道宇, 牟甜甜, 赵祚全,等. 新型18F标记心肌灌注显像剂的PET显像实验研究[J]. 中国医学装备, 2015,12(6):50-53. DOI:10.3969/J.ISSN.1672-8270.2015.06.016. Wang DY, Mou TT, Zhao ZQ, et al. The preliminary experimental study of a novel 18F-labeled myocardial perfusion imaging agent for PET imaging[J]. China Med Equipment, 2015, 12(6):50-53.
[13] 汪娇, 李剑明. PET/CT正电子心肌灌注显像剂的研究进展[J].中国医学影像学杂志, 2014, 138(11):877-880. DOI:10.3969/j.issn.1005-5185.2014.11.021. Wang J, Li JM. Research progress of PET/CT myocardial perfusion imaging agent[J]. Chin J Med Imaging, 2014, 138(11):877-880.
[14] Yu M, Guaraldi MT, Mistry M, et al. BMS-747158-02:a novel PET myocardial perfusion imaging agent[J]. J Nucl Cardiol, 2007, 14(6):789-798. DOI:10.1016/j.nuclcard.2007.07.008.
[15] Maddahi J, Czernin J, Lazewatsky J, et al. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET:dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest[J]. J Nucl Med, 2011, 52(9):1490-1498. DOI:10.2967/jnumed.111.092528.
[16] Uren NG, Crake T, Lefroy DC, et al. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction[J]. N Engl J Med, 1994, 331(4):222-227. DOI:10.1056/NEJM199407283310402.
[17] Parkash R, Dekemp RA, Ruddy TD, et al. Potential utility of Rubidium 82 PET quantification in patients with 3-vessel coronary artery disease[J]. J NuclCardiol, 2004, 11(4):440-449. DOI:10.1016/j. nuclcard.2004.04.005.
[18] Yoshinaga K, Katoh C, Manabe O, et al. Incremental diagnostic value of regional myocardial blood flow quantifcation over relative perfusion imaging with generator-produced rubidium-82 PET[J]. Circ J, 2011, 75(11):2628-2634. DOI:org/10.1253/circj.CJ-11-0502.
[19] Fiechter M, Ghadri JR, Gebhard C, et al. Diagnostic value of 13N-ammonia myocardial perfusion PET:added value of myocardial flow reserve[J]. J Nucl Med, 2012, 53(8):1230-1234. DOI:10.2967/jnumed.111.101840.
[20] Yoshinaga K, Tomiyama Y, Tamaki N, et al. Myocardial blood flow quantification using positron-emission tomography:analysis and practicein the clinical setting[J]. Circ J, 2013, 77(7):1662-1671. DOI:10.1253/circj.CJ-13-0235.
[21] 田丛娜, 魏红星, 张晓丽. PET心肌灌注显像测定心肌血流量及冠状动脉血流储备的研究进展[J].国际放射医学核医学杂志, 2012, 36(5):274-279. DOI:10.3760/cnla.j.issn.1673-4114. 2012. 05.004. Tian CN, Wei HX, Zhang XL. Progress of myocardial blood flow and coronary flow reserve measurement using PET myocardial perfusion imaging[J]. Int J Radiat Med Nucl Med, 2012, 36(5):274-279.
[22] Patel MR, Bailey SR, Bonow RO, et al. ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 Appropriate Use Criteria for Diagnostic Catheterization:A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American H eart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons[J]. J Am Coll Cardiol, 2012, 59(22):1995-2027. DOI:10.1016/j.jacc.2012. 03.003.
[23] Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update:a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography[J]. J Am Coll Cardiol, 2012, 59(9):857-881. DOI:10.1016/j.jacc.2011.12.001.
[24] Di Carli MF, Dorbala S. Integrated PET/CT for cardiol imaging[J]. Q J Nucl Med Mol Imaging, 2006, 50(1):44-52.
[25] Beanlands RS, Dekemp RA, Smith S, et al. F-18-Fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function[J]. Am J Cardiol, 1997, 79(8):1092-1095. DOI:10.1016/S0002-9149(97)00054-4.
[26] Taqueti VR, Hachamovitch R, Murthy VL, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently ofluminal angiographic severity and modifies the effectof early revascularization[J]. Circulation, 2015, 131(1):19-27. DOI:10.1161/CIRCULATIONAHA.114.011939.
[27] Dorbala S, Di Carli MF. Cardiac PET perfusion:prognosis, risk stratification, and clinical management[J]. Semin Nucl Med, 2014, 44(5):344-357. DOI:10.1053/j.semnuclmed.2014.05.003.
[28] Dorbala S, Di Carli MF, Beanlands RS, et al. Prognostic value of stress myocardial perfusion positron emission tomography:results from a multicenter observational registry[J]. J Am CollCardiol, 2013, 61(2):176-184. DOI:10.1016/j.jacc.2012.09.043.
[29] Dorbala S, Hachamovitch R, Curillova Z, et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF[J]. JACC Cardiovasc Imaging, 2009, 2(7):846-854. DOI:10.1016/j.jcmg.2009.04.009.
[30] Farhad H, Dunet V, Bachelard K, et al. Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging[J]. Eur Heart J Cardiovasc Imaging, 2013, 14(12):1203-1210. DOI:10.1093/ehjci/jet068.
[31] Valenta I, Quercioli A, Vincenti G, et al. Structuralepicardial disease and microvascular function are determinants of an abnormal longitudinal myocardial blood flow difference in cardiovascular risk individuals as determined with PET/CT[J]. J Nucl Cardiol, 2010, 17(6):1023-1033. DOI:10.1007/s12350-010-9272-9.
[32] De Bruyne B, Hersbach F, Pijls NH, et al. Abnormalepicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography[J]. Circulation, 2001, 104(20):2401-2406.
[33] Valenta I, Wahl RL, Schindler TH. Longitudinal myocardial blood flow gradient and CAD detection[J]. Curr Cardiol Rep, 2015, 17(1):550. DOI:10.1007/s11886-014-0550-z.
[34] Valenta I, Quercioli A, Schindler TH, et al. Diagnostic value of PET-Measured longitudinal flow gradient for the identification of coronary artery disease[J]. JACC Cardiovasc Imaging, 2014, 7(4):387-396. DOI:10.1016/j.jcmg.2014.01.001.
[35] Lanza GA, Crea F. Primary coronary microvascular dysfunction:clinical presentation, pathophysiology, and management[J]. Circulation, 2010, 121(21):2317-2325. DOI:10.1161/CIRCULATI ONAHA.109.900191.
[36] Leung DY, Leung M. Non-invasive/invasive imaging:significance and assessment of coronary microvasculardysfunction[J]. Heart, 2011, 97(7):587-595. DOI:10.1136/hrt.2009.183327.
[37] Cecchi F, Olivotto I, Gistri R, et al. Coronarymicrovascular dysfunction and prognosis in hypertrophic cardiomyopathy[J]. N Engl J Med, 2003, 349(11):1027-1035. DOI:10.1056/NEJMoa025050.
[38] Olivotto I, Cecchi F, Gistri R, et al. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy[J]. J Am Coll Cardiol, 2006, 47(5):1043-1048. DOI:10.1016/j.jacc.2005.10.050.
[39] Castagnoli H, Ferrantini C, Coppini R, et al. Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy:a 2016 reappraisal[J]. Eur J Nucl Med Mol Imaging, 2016, 43(13):2413-2422. DOI:10.1007/s00259-016-3465-7.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[3]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[4]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[5]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[6]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[7]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[8]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[11]汪娇,李剑明.18F-FDG PET心肌代谢显像在心肌存活诊断中的应用进展[J].国际放射医学核医学杂志,2015,39(3):252.[doi:10.3760/cma.j.issn.1673-4114.2015.03.014]
Wang Jiao,Li Jianming.Development of 18F-FDG PET myocardial metabolic imaging in the diagnosis of myocardial survival[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):252.[doi:10.3760/cma.j.issn.1673-4114.2015.03.014]
[12]陈越,李剑明.影像融合技术在冠心病中的临床应用进展[J].国际放射医学核医学杂志,2014,38(1):37.[doi:10.3760/cma.j.issn 1673-4114.2014.01.008]
Chen Yue,Li Jianming.Advances on the clinical applications of the image fusion techniques in coronary heart disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):37.[doi:10.3760/cma.j.issn 1673-4114.2014.01.008]
[13]张国建,王雪梅,刘艳阳.PET-CT在冠心病诊断中的临床应用及新进展[J].国际放射医学核医学杂志,2010,34(5):274.[doi:10.3760/cma.j.issn.1673-4114.2010.05.005]
ZHA NG Guo-jian,WANG Xue-mei,LIU Yan-yang.New progress and clinical application of PET-CT in coronary artery disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(6):274.[doi:10.3760/cma.j.issn.1673-4114.2010.05.005]